Medical device company profile

MedicubeX

Finnish medical technology company developing and supplying autonomous eHealth Stations for vital-sign measurement and connected care.

Medical Device Manufacturer and DeveloperDiagnostics & ImagingPhysiological Assessment

Headquarters🇫🇮Helsinki, Finland

Founded2020

Commercial statusCommercially availableCommercial eHealth Station medical system with deployments in Europe.

Employees2–10 ^[2]LinkedIn company-size range · Checked 2026-11-04

Estimated revenueNot confirmed

Disclosed funding€3.4 million ^[1]Completed share issue organized with Springvest, reported November 2025.

Official websitewww.medicubex.com ↗

Company overview

MedicubeX is a Helsinki-based medical technology company founded in March 2020 by Vili Kostamo and Heikki Rautajoki. Its eHealth Station is a self-service booth that combines medical measurement devices, software and connectivity to support health checks and remote consultations.

The station collects measurements such as blood pressure, pulse, oxygen saturation, temperature, ECG and body composition, depending on configuration. It is used in healthcare facilities and other settings to automate routine measurements and provide information for cardiovascular and metabolic risk assessment.

MedicubeX supplies and supports the integrated station, with deployments across Finland and other European markets. Its role is to develop the complete measurement workflow and connected system; individual measurement technologies and analytical functions may come from specialist partners.

^{[1][2][3][4][5]}

Leadership

5 people

Vili Kostamo, MDCo-founder & Chief Executive Officer ^[4]

Heikki RautajokiCo-founder, Chair & Chief Financial Officer ^[4]

Taavi LaukkanenChief Revenue Officer ^[4]

Joona KostamoChief Technology Officer ^[4]

Erica YlimäkiHead of Marketing ^[4]

Products & regulatory status How does MedTechIndex get this information?

Summary

MedicubeX identifies the eHealth Station as an MDR Article 22 medical system. This describes an integrated system assembled from constituent products; it should not be interpreted as a standalone authorization for every proposed screening or analytical function. ^[5][4]

The company lists MHRA reference 35132 and describes European deployments. These identifiers and deployments are distinct from an FDA clearance. Heart auscultation and structural-heart assessment are listed as planned for 2027, rather than part of every currently deployed configuration. ^[3][4]

Regulatory snapshot How to read this snapshot

U.S. FDA

—
510(k) clearances: —
De Novo grants: —
PMA approvals: —
Recall events

Latest recorded source review: 2026-11-04.

Scope: selected product families.

Commercial portfolio snapshot

Documented commercial product families.

Integrated self-service medical measurement system

eHealth Station ↗

Autonomous measurement booth integrating vital-sign devices, software and connectivity. Available measurements and risk-assessment functions depend on the deployed configuration; the station can also support remote consultation workflows. ^[5]

Commercially available · MDR Article 22 medical system